ResidualPlaybeta

Nope Nope Nurses

Dark One! · 2022 · $19.99 · Adventure · deal grade B

  • Estimated net residual revenue: $897 to $1.3k per month
  • Opportunity: $2.1k per month at x1.85 dormancy
  • Estimated lifetime owners: 19.9k
  • 77%% positive across 662 reviews · 9.0 reviews/month

Why it's flagged

  • Developer silent for 18 months
  • Studio quiet across its whole catalog
  • Last build shipped 4.6 years ago
  • Store page localized in only 3 language(s)
  • Last discounted 0 months ago, 10 sales in the last 12 months
  • Proven demand elasticity: x1.5 review velocity during past deep sales

Analyst notes (AI-assisted)

A darkly comedic adult visual novel set in a dysfunctional hospital, blending psychological discomfort with character-driven storytelling and explicit content.

Nope Nope Nurses has accumulated $99k lifetime revenue across ~20k units with 77% positive sentiment and steady monthly residual income ($1.1k/mo mid-case). The game carries niche appeal, modest review velocity (9/mo), and a fading studio behind it, making it a quiet catalog acquisition candidate for publishers already managing adult visual novel portfolios or exploring dormant IP revival through localization and platform expansion. The 6% Russian localization gap and strong Asian market presence (428 Chinese reviews) suggest untapped regional revenue. Most realistic play: acquisition.

  • Risk: Adult visual novel market is narrow and seasonal; Shiravune's publishing capacity and Dark One!'s fading studio status raise questions about post-acquisition support or sequel likelihood.
  • Risk: Title carries explicit sexual content and psychological themes; platform storefronts and payment processors have varying tolerance, limiting distribution channels and marketing venues.
  • Risk: Built 55+ months ago on unknown engine; localization gaps and language support (3 languages vs. 11+ review languages) suggest porting or expansion would require fresh development investment.

This case as Markdown · Estimates carry ±30-50%% error per title.